Literature DB >> 19074954

Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.

Sucheta Doshi1, Nino Khetsuriani, Khatuna Zakhashvili, Levan Baidoshvili, Paata Imnadze, Amra Uzicanin.   

Abstract

BACKGROUND: In 2004-05, Georgia experienced large-scale concurrent measles and rubella outbreaks. We analysed measles and rubella epidemiology in Georgia to describe disease trends, determine the cause of the outbreaks, identify challenges to achieving disease elimination goals and propose interventions to overcome them.
METHODS: We reviewed national measles and rubella surveillance and vaccination coverage data, focusing on the 2004-05 outbreaks, and conducted a measles vaccine effectiveness (VE) study using data from a 2004 school-based outbreak.
RESULTS: Before 2004, the last large measles outbreak after measles vaccination was introduced (in 1966) in Georgia, was in 1988 (incidence rate, 36/100 000); the highest year for rubella was 1985 (110/100 000). During 2004-05, 8391 measles cases and 5151 rubella cases were reported (most of them diagnosed clinically). Of 358 suspected measles cases tested, 181 (51%) were positive for measles-IgM antibody; of 240 suspected rubella cases tested, 50 (21%) were positive for rubella-IgM antibody. Over 90% of measles cases were in persons born after 1979; 90% of rubella cases were in persons born after 1987. Approximately 41% of measles cases and 88% of rubella cases were unvaccinated. Estimated measles VE (>/=1 vs 0 doses) was 86% (95% CI, 58-96%).
CONCLUSIONS: The outbreak likely resulted from failure to vaccinate rather than vaccine failure. Susceptible persons likely accumulated due to the long absence of large outbreaks and decreased coverage after the collapse of Soviet Union. To interrupt measles and rubella transmission in Georgia and achieve disease elimination goals by 2010, supplementary immunization activities should target children and young adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074954     DOI: 10.1093/ije/dyn261

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

Review 1.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

2.  Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.

Authors:  Matthew J Binnicker; Deborah J Jespersen; Leonard O Rollins
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

Review 3.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

6.  Challenges to Achieving Measles Elimination, Georgia, 2013-2018.

Authors:  Nino Khetsuriani; Ketevan Sanadze; Rusudan Chlikadze; Nazibrola Chitadze; Tamar Dolakidze; Tamta Komakhidze; Lia Jabidze; Shahin Huseynov; Myriam Ben Mamou; Claude Muller; Khatuna Zakhashvili; Judith M Hübschen
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

7.  Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts.

Authors:  N Khetsuriani; N Chitadze; S Russell; M Ben Mamou
Journal:  Epidemiol Infect       Date:  2019-12-11       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.